Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19- Infection With SARS-CoV-2 Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04817319
What this trial is testing

Risk of Contamination by COVID-19 During Oral Care With Aerosolization

Who this might be right for
Contamination by COVID 19 During Oral Care
Assistance Publique - Hôpitaux de Paris 18
Early research (Phase 1)Study completedNCT04593641
What this trial is testing

This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)

Who this might be right for
SARS-CoV-2 Infection
Celltrion 18
Not applicableStudy completedNCT04393428
What this trial is testing

Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19)

Who this might be right for
COVID-19Renal Replacement TherapyAcute Kidney Injury
University Hospital, Montpellier 100
Testing effectiveness (Phase 2)Study completedNCT05911009
What this trial is testing

To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID

Who this might be right for
Long Covid
Berlin Cures GmbH 119
Not applicableStudy completedNCT04490200
What this trial is testing

Effectiveness of a Novel Respirator With Chitosan Nanoparticles

Who this might be right for
Covid19SARS-CoV InfectionWorker-Patient Transmission, Healthcare
University of Brasilia 300
Large-scale testing (Phase 3)Study completedNCT04510493
What this trial is testing

Canakinumab in Patients With COVID-19 and Type 2 Diabetes

Who this might be right for
Coronavirus InfectionDiabetes Mellitus, Type 2
University Hospital, Basel, Switzerland 116
Not applicableStudy completedNCT04343404
What this trial is testing

Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19

Who this might be right for
Respiratory Distress Syndrome
University Hospital, Strasbourg, France 100
Large-scale testing (Phase 3)UnknownNCT04351152
What this trial is testing

Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19) Pneumonia
Humanigen, Inc. 520
Not applicableUnknownNCT04743947
What this trial is testing

Vaccination Against COVID-19 in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Stage 5 on DialysisChronic Kidney Disease Stage 5 With TransplantVaccine Response Impaired
Heinrich-Heine University, Duesseldorf 400
Large-scale testing (Phase 3)Study completedNCT05973006
What this trial is testing

Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines

Who this might be right for
COVID-19
Novavax 400
Large-scale testing (Phase 3)Study completedNCT04955626
What this trial is testing

To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 16,372
Large-scale testing (Phase 3)Ended earlyNCT04325633
What this trial is testing

Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection

Who this might be right for
COVID-19
Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)Study completedNCT05112848
What this trial is testing

Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19)

Who this might be right for
SARS-CoV-2 Infection
Novavax 384
Testing effectiveness (Phase 2)UnknownNCT04457726
What this trial is testing

Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

Who this might be right for
COVID-19
KK Women's and Children's Hospital 18
Testing effectiveness (Phase 2)UnknownNCT04395456
What this trial is testing

The C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)

Who this might be right for
Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19)
Amyndas Pharmaceuticals S.A. 144
Testing effectiveness (Phase 2)WithdrawnNCT05029856
What this trial is testing

Evaluation of the Safety and Immunogenicity of SII Vaccine Constructs Based on the SARS-CoV-2 (COVID-19) Variant in Adults

Who this might be right for
Covid19
Novavax
Not applicableStudy completedNCT04343781
What this trial is testing

National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19

Who this might be right for
SARS-CoV-2COVID-19
University Hospital, Angers 353
Not applicableUnknownNCT04323514
What this trial is testing

Use of Ascorbic Acid in Patients With COVID 19

Who this might be right for
Hospitalized Patients With Covid-19 Pneumonia
University of Palermo 500
Early research (Phase 1)UnknownNCT05212532
What this trial is testing

A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms

Who this might be right for
COVID-19 PneumoniaCOVID-19 Respiratory InfectionCOVID-19 Acute Respiratory Distress Syndrome
EOM Pharmaceuticals 40
Testing effectiveness (Phase 2)Ended earlyNCT04410354
What this trial is testing

Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19

Who this might be right for
COVID-19
ViralClear Pharmaceuticals, Inc. 44
Next Page